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To utilize Gaussian mixture model (GMM) for the quantification of chronic obstructive pulmo-
nary disease (COPD) and to evaluate the combined use of multiple types of quantification.
Materials and methods
Eighty-seven patients (67 men, 20 women; age, 67.4 ± 11.0 years) who had undergone
computed tomography (CT) and pulmonary function test (PFT) were included. The hetero-
geneity of CT attenuation in emphysema (HC) was obtained by analyzing a distribution of
CT attenuation with GMM. The percentages of low-attenuation volume in the lungs (LAV),
wall area of bronchi (WA), and the cross-sectional area of small pulmonary vessels (CSA)
were also calculated. The relationships between COPD quantifications and the PFT results
were evaluated by Pearson’s correlation coefficients and through linear models, with the
best models selected using Akaike information criterion (AIC).
Results
The correlation coefficients with FEV1 were as follows: LAV, −0.505; HC, −0.277; CSA,
0.384; WA, –0.196. The correlation coefficients with FEV1/FVC were: LAV, –0.640; HC, –
0.136; CSA, 0.288; WA, –0.131. For predicting FEV1, the smallest AIC values were obtained
in the model with LAV, HC, CSA, and WA. For predicting FEV1/FVC, the smallest AIC values
were obtained in the model with LAV and HC. In both models, the coefficient of HC was statis-
tically significant (P-values = 0.000880 and 0.0441 for FEV1 and FEV1/FVC, respectively).
Conclusion
GMM was applied to COPD quantification. The results of this study show that COPD sever-
ity was associated with HC. In addition, it is shown that the combined use of multiple types
of quantification made the evaluation of COPD severity more reliable.







Citation: Nishio M, Tanaka Y (2018) Heterogeneity
in pulmonary emphysema: Analysis of CT
attenuation using Gaussian mixture model. PLoS
ONE 13(2): e0192892. https://doi.org/10.1371/
journal.pone.0192892
Editor: Heinz Fehrenbach, Forschungszentrum
Borstel Leibniz-Zentrum fur Medizin und
Biowissenschaften, GERMANY
Received: June 27, 2017
Accepted: January 18, 2018
Published: February 14, 2018
Copyright: © 2018 Nishio, Tanaka. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This study was supported by JSPS
KAKENHI (Grant Number JP16K19883). The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation,
which is usually progressive and not fully reversible [1]. COPD can lead to irreversible struc-
tural changes such as remodeling of airways and destruction of lung parenchyma. These struc-
tural changes are caused by abnormal inflammatory response toward cigarette smoke or other
noxious gases. COPD is in effect a syndrome, with elements of bronchitis, airway hyperreactiv-
ity, inflammation, and emphysema in variable proportions [2].
Computed tomography (CT) and computer software made it possible to quantitatively eval-
uate the structural changes in the lungs caused by COPD, and quantitative evaluation of CT
was more sensitive than visual assessment for evaluating emphysema [3]. Although clinical
evaluation of CT images is usually qualitative or semi-quantitative, the qualitative or semi-
quantitative evaluation of COPD has suffered from inter-observer variability [4]. Quantitative
evaluation of CT images has the potential to identify phenotypes of COPD and assess the pro-
gression of COPD.
The most widely used method to quantify emphysema on CT is the percentage of low-
attenuation volume in lungs (LAV) [5]. However, no single type of quantification can guaran-
tee an accurate assessment of COPD severity. There is, therefore, a need for a new way to
quantify COPD. Many types of COPD quantification have been suggested in previous studies:
LAV and D (D was obtained by analyzing the size distribution of low-attenuation lung
regions) for emphysema [4, 6]; the percentage of wall area (WA) for airway wall change [7, 8];
the percentage of the cross-sectional area of small pulmonary vessels (CSA) for vascular alter-
ation [9]; and Patlak analysis of 18F-fluorodeoxyglucose positron emission tomography for the
inflammatory state [10]. Combining these methods, such as a combination of LAV and WA,
has been investigated and shown to be superior to using a single type of quantification [7, 11–
14].
We hypothesized that heterogeneity of CT attenuation was useful for quantifying COPD.
Although spatial heterogeneity of emphysema was investigated in previous studies [15, 16],
here we focused on the heterogeneity of CT attenuation. To assess this, we used Gaussian mix-
ture model (GMM). In GMM, the distribution of CT attenuation is approximated by a mixture
of Gaussian distributions for which the mean and variance can be calculated. Because variance
reflects the heterogeneity of a Gaussian distribution, the heterogeneity of CT attenuation can
be calculated by GMM. In addition, we evaluated combinations of multiple types of quantifica-
tions, in contrast to the previous studies, which mainly investigated the combined use of just
two types. We speculated that the severity of COPD could be assessed more accurately by the
use of multiple types of quantification.
In summary, the aims of the current study were: i) to validate GMM for COPD quantifica-
tion by analyzing CT attenuation distribution in the lungs, ii) to assess whether the heteroge-
neity of CT attenuation obtained from GMM was useful for COPD quantification, and iii) to
evaluate the combined use of LAV, CSA, WA, and heterogeneity of CT attenuation.
Materials and methods
This retrospective study was approved by the institutional review boards of Institute of Bio-
medical Research and Innovation and Chibune General Hospital. The acquisition of informed
consent was waived by the review boards.
Patients
Patients who visited our institution because of their respiratory symptom (such as chronic
cough and dyspnea) were examined retrospectively. If the patient underwent CT and
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pulmonary function test (PFT) and the interval between CT and PFT was less than 90 days, the
patient was included in the current study. COPD was diagnosed based on the Global Initiative
for Chronic Obstructive Lung Disease criteria [1]. These patients had no exacerbation at the
CT and PFT examinations.
This study included 87 consecutive patients (67 men, 20 women; age, 67.4 ± 11.0 years). 39
patients were diagnosed with COPD; 38 were smokers without COPD; and 10 were non-
smokers. The mean smoking history of all the 87 patients, the 39 patients with COPD, and the
38 smokers without COPD were 45.8 ± 38.63, 58.3 ± 45.8, and 45.1 ± 24.1 pack-years, respec-
tively. The mean interval between CT and PFT was 17.3 ± 39.1 days.
CT scan
Noncontrast helical CT scans were acquired from the lung apices through the lung bases with
a 320-detector-row scanner (Aquilion ONE; Toshiba Medical Systems, Otawara, Japan) by
using automated exposure control. The scan parameters were as follows: noise index, 10; tube
current, 200 ± 66.5 mA; tube potential, 120 kV; gantry rotation time, 0.35 s in one patient, 0.6 s
in two patients, and 0.5 s in all the other patients. After receiving careful instruction about
breathing, the patients were scanned in the supine position during a deep inspiratory breath
hold. To reduce computational cost of GMM, raw CT data were reconstructed into 5-mm-
thick images with soft tissue kernel (FC 13 or 14). The CT scanner was calibrated regularly.
Pulmonary function test
The PFT was performed with an automated spirometer (HI-801 or CHESTAC-8900, CHEST
M.I., INC., Tokyo, Japan). Vital capacity, forced expiratory volume in one second (FEV1),
forced vital capacity (FVC), and the ratio of forced expiratory volume in one second to forced
vital capacity (FEV1/FVC), were obtained. Apart from FEV1/FVC, these were expressed as per-
centages of the standard predicted values.
Image preprocessing
The acquired CT images were processed by our prototype software. First, the lungs were auto-
matically segmented from the CT images using region growing, an auto-detected seed point,
and a threshold at −500 HU.
The CT attenuation (HU) of all the lung voxels were collected, and the mean, variance,
skewness, and kurtosis of the CT attenuation distribution were calculated to examine the dis-
tribution of lung voxels. Then, using GMM, the distribution of CT attenuation was approxi-
mated by a mixture of Gaussian distributions, and the mean and variance of each distribution






where, K is the number of Gaussian distributions determined experimentally, N(μi, s2i ) is a
Gaussian distribution with mean μi and variance s2i , and γi gives the relative weightings of the
distributions and satisfies
PK
i¼1gi ¼ 1; gi  0 ði ¼ 1; 2; 3; . . . ;KÞ. K = 2, 3, 4, 5, 6, 7, and 8
were tested in the current study, and K = 4 was selected based on results of preliminary experi-
ments (for the preliminary experiments, please refer to Tables B and C in S1 File of Supporting
information). When a larger K was used, the computational cost of GMM was unacceptable.
The mean μi and variance s2i (i = 1, 2, 3, . . ., K) obtained by GMM were sorted by the value of
μi. As a result, the variance s21 corresponded to the lowest mean μ1. The mean μ1 and variance
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s2
1
were used for the detailed statistical analysis (s2
1
was referred to as HC in the current study).
Here, dimensions of μ1 and HC obtained by GMM were HU and HU2, respectively. Python
(version 2.7; http://www.python.org/) and scikit-learn (version 0.17.1; http://scikit-learn.org/)
were used for performing GMM.
LAV was obtained as the percentage of the number of low-attenuation lung voxels to the
total number of lung voxels [5]. In the current study, 5 different thresholds were evaluated,
and −970 HU was selected as the threshold of LAV (for the results of 5 different thresholds,
please refer to Table A in S1 File of Supporting information). CSA values were calculated by
applying several modifications to the method described in the previous study [9]. First,
python-2.7 and the OpenCV package for python were used for blob detection. Second, CT
images covering the whole chest were analyzed using segmented lungs. Third, the calculation
of CSA was fully automatic. Last, the slice thickness of CT images differed from that of the pre-
vious study. Because of these differences, multiple thresholds of CT attenuation and other CSA
parameters were tested, and the optimal combination of the parameters was selected (in
Table D in S1 File of Supporting information, the effect of CSA parameters was shown). The
optimal parameters were as follows: threshold of CT attenuation, −730 HU; range of circular-
ity, 0.9–1.0; size of vessel area, 5–10 mm2. Measurement of the airway wall change was per-
formed using AirwayInspector, which is available at http://airwayinspector.acil-bwh.org/ and
was used for the previous study [17, 18]. In each patient, the fourth generation of bronchi at
RB1, LB1+2, and RB10 were selected by a consensus reading of two board-certified radiologists
(MN and YT). The software detected the inner and outer boundaries of the airway wall at the
selected bronchi, and WA was calculated automatically. The mean value of WA across the
three bronchi was used for the statistical analysis.
Statistical analysis
To test whether the quantification reflected the severity of COPD, Pearson’s correlation coeffi-
cients were calculated between the results of quantification and PFT. Correlation was also eval-
uated between LAV and μ1 and between LAV and mean of the CT attenuation distribution.
Next, linear models were used to investigate the relationship between the PFT results and
the COPD quantification. One set of linear models was built to predict FEV1 using the COPD
quantification, and another set was built to predict FEV1/FVC. In each set, combinations of
LAV, CSA, WA, and HC were used as predictor variables. Because the values of predictor vari-
ables were not normally distributed, log transformation was applied to the predictor variables.
The coefficients of the predictor variables were evaluated with their P-values, and the best
models were selected as those with the lowest values based on Akaike information criterion
values (AIC) [19]. According to the previous studies, the difference in AIC of more than 1 or 2
was regarded as significant [20, 21]. All analyses were performed using R-3.1.0 (available at
http://www.R-project.org/). P-values less than 0.05 were considered statistically significant.
Results
Patient characteristics and the results of the PFT and COPD quantification values are summa-
rized in Table 1. Table 2 shows the correlations coefficients between PFT results and COPD
quantification values. Figs 1 and 2 show scatter plots of FEV1 and FEV1/FVC, respectively,
against the COPD quantification values. Fig 3 shows the schematic illustration of histograms
of CT attenuation in lungs and the Gaussian distributions obtained by GMM.
Table 2 showed that LAV, the variance of the distribution, and CSA had relatively strong
correlations with FEV1. LAV, μ1, and the mean of the distribution had relatively strong corre-
lations with FEV1/FVC. The correlation coefficient between LAV and μ1 and that between
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LAV and the mean of the distribution were −0.811 and −0.629, respectively. These results sug-
gest that LAV, μ1, and the mean of the distribution were related to the severity of emphysema.
Tables 3 and 4 show the results of the linear models, and AIC values of all the models using
LAV, HC, CSA and WA were shown in Tables E and F in S1 File of Supporting information.
In Table 3, the models with HC had more accurate predictability than those without HC. This
means that heterogeneity of CT attenuation in emphysema was independently useful for
Table 1. Summary of patient characteristics, PFT results, COPD quantification values.
All Non-smoker Smoker without COPD COPD
Variables Mean SD Mean SD Mean SD Mean SD
N 87 10 38 39
Age (year) 67.4 10.98 67.5 14.03 65.71 11.44 69.03 9.66
Sex = M (number of male) 67 1 33 33
Smoking history (pack year) 45.8 38.63 0 0 45.05 24.06 58.29 45.83
FVC (%) 91.17 23.93 98.82 19.24 93.98 25.33 86.47 23.19
FEV1/FVC (%) 67.74 15.95 81.97 5.19 78.87 6.15 53.25 11.80
FEV1 (%) 73.54 25.96 99.61 12.53 85.41 21.33 55.29 19.56
VC (%) 97.12 23.68 98.32 24.34 100.85 24.16 93.18 23.03
Mean of CT attenuation distribution (HU) −862.48 35.11 −839.63 34.54 −850.8 32.08 −879.7 30.47
Variance of CT attenuation distribution (HU2) 8100 1920 7260 1490 7990 2180 8420 1690
Skewness of CT attenuation distribution 1.81 0.49 1.82 0.47 1.77 0.58 1.83 0.39
Kurtosis of CT attenuation distribution 3.78 2.06 3.73 1.74 3.69 2.45 3.88 1.74
LAV (%) 6.22 9.89 0.72 0.30 2.11 2.71 11.64 12.62
μ1 (HU) −917.8 38.06 −890.3 25.10 −904.9 28.38 −937.3 39.87
HC (HU2) 702.2 748.4 483.4 175.1 697.3 992.1 763.1 534.3
CSA (%) 0.00599 0.00304 0.00817 0.00265 0.00635 0.00348 0.00507 0.00229
WA (%) 61.37 7.38 62.07 10.5 60.33 7.68 62.21 6.14
Note: The PFT results were expressed as percentages of the standard predicted values, apart from FEV1/FVC. Abbreviations: CSA, percentage of cross-sectional area for
small pulmonary vessels; FEV1, forced expiratory volume in one second; FEV1/FVC, ratio of forced expiratory volume in one second to forced vital capacity; FVC,
forced vital capacity; HC, heterogeneity of CT attenuation in emphysema; LAV, percentage of low-attenuation volume in lungs; PFT, pulmonary function test; VC, vital
capacity. WA, percentage of wall area; μ1, the lowest mean from the Gaussian mixture model.
https://doi.org/10.1371/journal.pone.0192892.t001
Table 2. Pearson’s correlation coefficients between the quantitative evaluation of COPD and PFT results.
Variables FEV1 FEV1/FVC
Mean of CT attenuation distribution (HU) 0.194 0.513
Variance of CT attenuation distribution (HU2) −0.300 −0.222
Skewness of CT attenuation distribution 0.184 −0.039
Kurtosis of CT attenuation distribution 0.167 −0.031
LAV (%) −0.505 −0.640
μ1 (HU) 0.292 0.554
HC (HU2) −0.277 −0.136
CSA (%) 0.384 0.288
WA (%) −0.196 −0.131
Abbreviations: CSA, percentage of cross-sectional area for small pulmonary vessels; FEV1, forced expiratory volume
in one second; FEV1/FVC, ratio of forced expiratory volume in one second to forced vital capacity; HC,
heterogeneity of CT attenuation in emphysema; LAV, percentage of low-attenuation volume in lungs; WA,
percentage of wall area; μ1, the lowest mean from the Gaussian mixture model.
https://doi.org/10.1371/journal.pone.0192892.t002
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quantifying COPD severity. Model 4 in Table 3 (with predictor variables LAV, HC, CSA, and
WA) had the smallest AIC among the models examined in this study, and this model was the
best among those in Table 3 and Table E in S1 File of Supporting information. Table 4 shows
that the smallest AIC was obtained in Model 2, which included LAV and HC as predictor vari-
ables. Table F in S1 File of Supporting information shows that the difference of AIC values
between the model with LAV and HC and that with LAV, HC, and CSA was small, which
means that there was not one best model. However, for the models to predict FEV1/FVC, com-
bining LAV and HC was better than LAV alone.
Discussion
The current study demonstrated three main points: i) GMM could be used for quantifying the
severity of COPD; ii) the heterogeneity of CT attenuation in emphysema obtained from GMM
Fig 1. Scatter plots of FEV1 against COPD quantification. A)–D) show the plots for LAV, CSA, WA, and HC, respectively.
Abbreviations: FEV1, forced expiratory volume in one second; LAV, percentage of low-attenuation volume in the lungs; HC,
heterogeneity of CT attenuation in emphysema; CSA, percentage of cross-sectional area for small pulmonary vessels; WA, percentage
of wall area.
https://doi.org/10.1371/journal.pone.0192892.g001
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was useful for quantifying COPD; and iii) Combination of COPD quantification values
allowed COPD severity to be evaluated accurately.
To our knowledge, this was the first study to apply GMM to COPD quantification. Previ-
ously, GMM has been used for several biomedical or medical applications [22, 23]. We hypoth-
esized that the distribution of CT attenuation consisted of multiple components, and that
these components could be captured separately as Gaussian distributions by using GMM. In
this study, we examined the relationship between emphysema quantification (LAV) and the
Gaussian distribution with the lowest mean (μ1) obtained with GMM. The correlation between
LAV and μ1 was strong (correlation coefficient = −0.811); hence, this suggests that the Gauss-
ian distribution with the lowest mean μ1 corresponded to the emphysema component. This
result supports our hypothesis.
Fig 2. Scatter plots of FEV1/FVC against COPD quantification. A)–D) show the plots for LAV, CSA, WA, and HC, respectively.
Abbreviations: FEV1/FVC, ratio of forced expiratory volume in one second to forced vital capacity; LAV, percentage of low-
attenuation volume in the lungs; HC, heterogeneity of CT attenuation in emphysema; CSA, percentage of cross-sectional area for
small pulmonary vessels; WA, percentage of wall area.
https://doi.org/10.1371/journal.pone.0192892.g002
Analysis of pulmonary emphysema using GMM
PLOS ONE | https://doi.org/10.1371/journal.pone.0192892 February 14, 2018 7 / 13
We also hypothesized that the heterogeneity of CT attenuation (HC) was useful for COPD
quantification. Because the Gaussian distribution with the lowest mean μ1 corresponded to the
Fig 3. Histogram of CT attenuation for lungs and result of GMM in 59-year-old man with COPD. A) shows the histograms of CT attenuation for lungs when width
of histogram bar was 1 HU. B) shows the four Gaussian distributions obtained by GMM. The mixture of these four Gaussian distributions approximated the histogram.
The Gaussian distribution with the lowest mean is represented by the red solid line, which corresponds to the distribution of emphysema. Abbreviations: GMM,
Guassian mixture model; COPD, chronic obstructive pulmonary disease.
https://doi.org/10.1371/journal.pone.0192892.g003
Table 3. Results of the linear model between FEV1 and the COPD quantification.
Model index Predictor variable Coefficient P-value AIC of model
1 794.8
LAV −9.42 1.58 x 10−6
2 785.2











Note: Log transformation was applied to values of predictor variables. Abbreviations: AIC, Akaike information criterion value; CSA, percentage of cross-sectional area
for small pulmonary vessels; FEV1, forced expiratory volume in one second; HC, heterogeneity of CT attenuation in emphysema; LAV, percentage of low-attenuation
volume in the lungs; WA, percentage of wall area.
https://doi.org/10.1371/journal.pone.0192892.t003
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distribution of emphysema, the variance of the Gaussian distribution with the lowest mean μ1
reflected the heterogeneity of CT attenuation in emphysema. Table 2 shows that HC was nega-
tively correlated with FEV1, and Tables 3 and 4 show that HC was independently useful for
COPD quantification, which verify our hypothesis. The previous studies showed that the spa-
tial distribution of emphysema was associated with COPD severity [15, 16]. In these studies,
LAV was used to assess the spatial distribution of emphysema. Because the CT attenuation of
lung voxels was binarized in LAV, the distribution of CT attenuation could not be assessed
using LAV. Our study investigated the distribution of CT attenuation in emphysema, and the
heterogeneous distribution of emphysema was associated with low FEV1.
While the Gaussian distribution with the lowest mean was investigated intensively, the
other Gaussian distributions were not examined in the current study. Both COPD and intersti-
tial lung abnormality were caused by smoking [17]. Interstitial lung abnormality was repre-
sented as relatively high density area, such as ground-glass opacity. We speculated that, using
GMM, the distribution of lung voxels in COPD patients might be divided into distributions of
normal lung tissue, emphysema, and interstitial lung abnormality. Therefore, it may be possi-
ble to use GMM for the assessment of interstitial lung abnormality and emphysema separately.
However, because it was difficult to quantify normal lung tissue and interstitial lung abnormal-
ity automatically, we focused on the Gaussian distribution with the lowest mean in the current
study.
The current study investigated the combined use of four types of COPD quantification
(LAV, HC, CSA, and WA). AIC values in Tables 3 and 4 and those in Tables E and F in S1 File
of Supporting information show that the model with four types of quantification was the best
for the prediction of FEV1, and that, for the prediction of FEV1/FVC, the model with LAV and
HC was better than that with LAV alone. The results of these linear models showed that LAV
and HC were independently useful for the COPD quantification. As shown in the previous
studies, LAV has been most widely used for emphysema quantification. In accordance with
these results, LAV was the strongest predictor in the linear models of our study. Our results
Table 4. Results of the linear model between FEV1/FVC and the COPD quantification.
Model index Predictor variable Coefficient P-value AIC of model
1 680.4
LAV −8.02 6.24 x 10−13
2 678.2
LAV −7.77 1.61 x 10−12
HC −4.39 0.0441
3 679.9








Note: Log transformation was applied to values of predictor variables. Abbreviations: AIC, Akaike information criterion value; CSA, percentage of cross-sectional area
for small pulmonary vessels; FEV1/FVC, ratio of forced expiratory volume in one second to forced vital capacity; HC, heterogeneity of CT attenuation in emphysema;
LAV, percentage of low-attenuation volume in the lungs; WA, percentage of wall area.
https://doi.org/10.1371/journal.pone.0192892.t004
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also showed that HC was significant predictor, supporting our hypothesis that heterogeneity
of CT attenuation in emphysema was associated with severity of COPD.
As shown in Table 2, the correlations between WA and FEV1 and between WA and FEV1/
FVC were relatively weak (coefficients = −0.196 and −0.131, respectively). Nakano et al. sug-
gested that measurements of large airway wall thickening could be used for COPD quantifica-
tion [7]. However, the study of Lee et al. failed to show a direct relationship between the
severity of PFT abnormality and WA [8]. Our results were intermediate between those of the
previous two studies. Although WA was measured by the consensus reading of the two radiol-
ogists with the aid of AirwayInspector, we speculate that measurement error caused by techni-
cal problems related to WA weakened the correlation between WA and the PFT results.
Population differences may be attributable to changes in correlation between WA and PFT
results; Nakano et al. included all smokers [7], Lee et al. included patients with moderate or
severe COPD [8], and we included non-smokers, smokers without COPD, and COPD
patients. In addition, the location where WA was measured affected the correlations between
WA and FEV1 and between WA and FEV1/FVC, because airflow limitation in COPD was
more closely related to WA in distal airway than that in proximal airways [24].
There are several limitations in the current study. First, this study was performed retro-
spectively, and the number of patients included in this study was relatively small. To confirm
our results, it will be necessary to use a large cohort of patients as a prospective study. Second,
the CT parameters used in this study were different from those commonly used in previous
studies; for example, use of automated exposure control and the thickness of CT images (thick-
ness = 5 mm) might affect our results for COPD quantification. Third, although the relation-
ship between results of PFT and COPD quantification was investigated in the current study,
those with clinical outcomes, health status, and disease progression of COPD were not exam-
ined. Because FEV1 correlated weakly with clinical outcomes and health status in COPD
patients [25], other types of metric should be used when comparing COPD quantification with
clinical outcomes or disease progression. We will perform a prospective study for investigating
whether results of GMM are correlated well with these factors. Last, we did not evaluate the
effect of cluster analysis. In a previous study [20], the usefulness of combined use of LAV and
D was examined for predicting PFT results. It is difficult to precisely compare the results
between the previous study and the current study because of the difference in study design.
However, the improvement of statistical model obtained by addition of D seems to be smaller
than by addition of HC based on the values of AIC. Therefore, it is speculated that the useful-
ness of D would be limited in the current study.
In conclusion, our results showed that GMM could be applied to COPD quantification, and
that COPD severity was associated with the heterogeneity of CT attenuation in emphysema. In
addition, combining COPD quantification values, including the heterogeneity of CT attenua-
tion in emphysema, improved the reliability of COPD severity evaluation.
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